Covid’s Long Shadow: Mourning in America
The ‘Grief Pandemic’ Will Torment Americans for Years
More than 5 million Americans lost a loved one to covid, and the ripple effects could lead to serious illness down the road.
Search
Filter
Clear All41-60 of 143 results
-
-
Doctors More Likely to Prescribe Opioids to Covid ‘Long Haulers,’ Raising Addiction Fears
Chronic pain from covid can linger for months after patients appear to recover from the disease.
By Liz Szabo -
Coronavirus Deranges the Immune System in Complex and Deadly Ways
Researchers are testing treatments to overcome autoimmune reactions that begin when the body’s defenses respond to the coronavirus.
By Liz Szabo -
Anti-Vaccine Activists Peddle Theories That Covid Shots Are Deadly, Undermining Vaccination
Thousands of people died shortly after inoculation, but their deaths weren’t related to getting a vaccine.
By Liz Szabo -
5 Reasons to Wear a Mask Even After You’re Vaccinated
Vaccination, face coverings and physical distancing are essential parts of a team effort against the coronavirus.
By Liz Szabo -
Many US Health Experts Underestimated the Coronavirus … Until It Was Too Late
Scientists learned the wrong lesson from past outbreaks, but Dr. Anthony Fauci doesn’t cast blame.
By Liz Szabo -
‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die
Scientists have found that some people have antibodies against parts of their own immune system, allowing viruses to multiply rapidly.
By Liz Szabo -
When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers
The Johnson & Johnson vaccine that the FDA cleared Saturday was 66% effective overall in preventing moderate to severe covid, while the Pfizer and Moderna vaccines were more than 90% effective. But the numbers aren’t exactly comparable. And all three shots prevent hospitalization and death.
By Arthur Allen and Liz Szabo -
Journalists Explore Inefficiency and Inequities of Vaccine Rollout
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Health Officials Worry Nation’s Not Ready for COVID-19 Vaccine
As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.
By Liz Szabo -
Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming
The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
By Liz Szabo -
Time to Discuss Potentially Unpleasant Side Effects of COVID Shots? Scientists Say Yes.
From the likelihood of achy, flu-like side effects to the need for two doses, weeks apart, consumers need to know now what to expect when vaccines to prevent COVID-19 roll out.
By JoNel Aleccia and Liz Szabo -
KHN on the Air This Week
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Scientists Warn Americans Are Expecting Too Much From a Vaccine
Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove the vaccines can reduce hospitalizations or deaths.
By Liz Szabo and JoNel Aleccia -
Fauci Unfazed as Scientists Rely on Unproven Methods to Create COVID Vaccines
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
By Liz Szabo -
Distrusting Trump, States Plan to Vet COVID Vaccines Themselves. Bad Idea, Say Experts.
California and at least five other states have said they may independently vet any vaccines. Experts warn that could needlessly confuse the public.
By JoNel Aleccia and Liz Szabo -
Signs of an ‘October Vaccine Surprise’ Alarm Career Scientists
President Donald Trump has the legal power to authorize a COVID vaccine over the objections of the Food and Drug Administration and vaccine manufacturers. Such a move could further erode public trust in a vaccine and foist an unsafe shot on Americans.
By Liz Szabo and JoNel Aleccia -
KHN on the Air This Week
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.
By Arthur Allen and Liz Szabo -
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster
Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn’t overcome vast obstacles.